What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Livio Trentin mostly deals with Immunology, Bronchoalveolar lavage, Cancer research, Chronic lymphocytic leukemia and Internal medicine.
His study focuses on the intersection of Immunology and fields such as Lung with connections in the field of Cellular immunity and Cytokine.
His biological study spans a wide range of topics, including T lymphocyte, Sarcoidosis, Pathology, Chemokine and CXCR3.
His Cancer research research incorporates themes from Mutation, Cell culture, CD70 and CD30.
His Chronic lymphocytic leukemia research integrates issues from Therapeutic strategy, Hairy cell leukemia and Telomerase, Telomerase reverse transcriptase.
The study incorporates disciplines such as Gastroenterology, Endocrinology, Surgery and Immunoglobulin heavy chain in addition to Internal medicine.
His most cited work include:
- BRAF mutations in hairy-cell leukemia (749 citations)
- Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study (648 citations)
- The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease (247 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Internal medicine, Chronic lymphocytic leukemia, Cancer research and Oncology.
His Immunology research includes elements of Cytotoxic T cell and Bronchoalveolar lavage, Lung.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Endocrinology.
His Endocrinology research focuses on subjects like Receptor, which are linked to Cytokine.
His Chronic lymphocytic leukemia study combines topics in areas such as Hairy cell leukemia, Antibody and Fludarabine.
His work deals with themes such as Kinase, Protein kinase A, Apoptosis, LYN and Signal transduction, which intersect with Cancer research.
He most often published in these fields:
- Immunology (41.10%)
- Internal medicine (32.19%)
- Chronic lymphocytic leukemia (26.71%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (32.19%)
- Chronic lymphocytic leukemia (26.71%)
- Ibrutinib (7.53%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Chronic lymphocytic leukemia, Ibrutinib, Oncology and Cancer research.
His work investigates the relationship between Internal medicine and topics such as Gastroenterology that intersect with problems in Chemotherapy and BEACOPP.
As part of his Leukemia and Immunology and Chronic lymphocytic leukemia studies, Livio Trentin is studying Chronic lymphocytic leukemia.
His study connects Polyneuropathy and Immunology.
His Oncology study incorporates themes from Complex Karyotype, Clinical trial, Retrospective cohort study and MEDLINE.
His Cancer research research includes themes of Apoptosis, Mantle cell lymphoma, Chemokine, Signal transduction and Kinase.
Between 2017 and 2021, his most popular works were:
- Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial (84 citations)
- Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact (49 citations)
- COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. (40 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Chronic lymphocytic leukemia, Internal medicine, Ibrutinib, Oncology and Cancer research.
The various areas that Livio Trentin examines in his Chronic lymphocytic leukemia study include Gastroenterology, Antibody, Rituximab and Bone marrow.
His Antibody study contributes to a more complete understanding of Immunology.
Borrowing concepts from Antibody titer, he weaves in ideas under Immunology.
His Cancer research research is multidisciplinary, relying on both Heat shock protein, Hsp70, HSF1, Chemotaxis and PI3K/AKT/mTOR pathway.
The concepts of his Leukemia study are interwoven with issues in Survival rate, Hematology and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
